Regulatory considerations in drug development for autism spectrum disorders

Eur Neuropsychopharmacol. 2021 Jul:48:47-48. doi: 10.1016/j.euroneuro.2021.03.002. Epub 2021 Mar 25.

Authors

Valentina Mantua¹, Tiffany Farchione²

Affiliations

¹ Food and Drug Administration, USA. Electronic address: [email protected].
² Food and Drug Administration, USA.

PMID: 33773885
DOI: 10.1016/j.euroneuro.2021.03.002

No abstract available

Keywords: Autism; Clinical trials; Drug development; Regulatory.

MeSH terms

Autism Spectrum Disorder* / drug therapy
Drug Development
Humans